Ionis Pharmaceuticals: Assessing the Remaining Upside After 80% Share Price Surge

Ionis Pharmaceuticals shares surged 80% after positive trial data from phase-3 studies. The company's pipeline drugs showed promising results, leading to a significant increase in the stock price. As a finance expert, I would caution that the upside may be limited given the already substantial rise in the share price.